Establishment of Regional Severe Trauma Management System

December 4, 2017 updated by: baoguojiang, Peking University People's Hospital

Establishment of Regional Severe Trauma Treatment System in 100 Counties: a National Multi-center, Cluster-randomized Controlled Trial

To evaluate the effects of trauma treatment team establishment on the treatment of patients with severe trauma.

Study Overview

Detailed Description

This is a national multi-center, cluster-randomized controlled trial. This cluster-randomized controlled trial will be performed, with counties as the randomization units. The included counties will be randomized into an experimental group and a control group. A trauma treatment team will be only established in the experimental group. The in-hospital mortality rate will be compared between the experimental and control groups to investigate the effects of trauma treatment team establishment on the treatment of patients with severe trauma.

Study Type

Interventional

Enrollment (Anticipated)

7250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

In this study, three-level subjects (counties, hospitals, and trauma patients) will be included according to the following inclusion and exclusion criteria:

  • inclusion:
  • Inclusion criteria of counties:

    • National counties and county-level administrative regions;
    • Local government and health management department have the desire and requirements to establish a standardized trauma emergency treatment system;
    • More than 500,000 people;
    • With pre-hospital emergency treatment system;
    • Trauma first aid needs: No less than 20 patients with severe trauma (ISS ≥ 16) throughout the county;
  • Inclusion criteria of hospitals:

    • With the most advanced regional treatment resources during the entire period from trauma recovery to rehabilitation for third-grade class A hospitals;
    • With basic trauma treatment resources for second-grade class A hospitals;
    • Trauma doctors are on call 24 hours a day and can participate in the early treatment of patients with trauma;
  • Inclusion criteria of patients:

    • Patients with acute trauma occurring within 48 hours;
    • Patients are transferred to trauma treatment center hospital or trauma treatment non-center hospitals;
    • Patients themselves go to or are transferred by their family members to the trauma treatment center hospital or trauma treatment non-center hospita;
  • Exclusion:
  • Exclusion criteria of counties:

    ○ All second-grade class A or third-grade class A hospitals in the county cannot establish a trauma treatment team because of various reasons;

  • Exclusion criteria of hospitals:

    ○ Hospitals can not establish a trauma treatment team because of various reasons;

  • Exclusion criteria of patients:

    • Patients with trauma from regions not included in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental group
The trauma treatment team will be established in the experimental group
Establishing the trauma management system included a trauma treatment team. The severe trauma treatment team will be composed by the physicians from departments of emergency, orthopedic trauma, urology, cardiothoracic surgery, neurosurgery, general surgery, anesthesiology, and ICU.
Active Comparator: control group
The trauma treatment team will not be established in this group,just establish the basic experimental settings
Establishing the trauma management system without a trauma treatment team.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
In-hospital mortality rate
Time Frame: from hospital admission to discharge, an average of 20 days
the percentage of patients who die after hospitalization for severe trauma in admitted patients with severe trauma.
from hospital admission to discharge, an average of 20 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality rate of patients with severe trauma within 30 days after trauma attack
Time Frame: within 30 days after trauma attack
the percentage of patients who die within 30 days after trauma attack in admitted patients with severe trauma
within 30 days after trauma attack
Mortality rate of patients with severe trauma within 30 days after discharge
Time Frame: within 30 days after discharge
the percentage of patients who die within 30 days after discharge in admitted patients with severe trauma
within 30 days after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: baoguo Jiang, MD, Peking University People's Hospital; Peking University Traffic Medical Center; China Trauma Rescue&Treatment Association

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2018

Primary Completion (Anticipated)

December 31, 2019

Study Completion (Anticipated)

December 31, 2019

Study Registration Dates

First Submitted

November 29, 2017

First Submitted That Met QC Criteria

December 4, 2017

First Posted (Actual)

December 6, 2017

Study Record Updates

Last Update Posted (Actual)

December 6, 2017

Last Update Submitted That Met QC Criteria

December 4, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergencies

Clinical Trials on trauma treatment team

Subscribe